Abacavir
Formulations: - Oral > Solid: 300 mg tablet (as sulfate) Indications: - Human immunodeficiency virus disease without mention of associated disease or condition, clinical stage unspecified Source: EML workbook import
MOQ: 1
Price on request
Antiretrovirals > Nucleoside/Nucleotide reverse transcriptase inhibitors catalogue banner
Antiretrovirals > Nucleoside/Nucleotide reverse transcriptase inhibitors
Imported from EML workbook.
All Antiretrovirals > Nucleoside/Nucleotide reverse transcriptase inhibitors (Showing 4 out of 4)
Lamivudine
Formulations: - Oral > Liquid: 50 mg per 5 mL Oral > Solid: 150 mg tablet Indications: - Human immunodeficiency virus disease without mention of associated disease or condition, clinical stage unspecified Source: EML workbook import
MOQ: 1
Price on request
Tenofovir Disoproxil Fumarate
Formulations: - Oral > Solid: 300 mg tablet (equivalent to 245 mg tenofovir disoproxil) Indications: - Human immunodeficiency virus disease without mention of associated disease or condition, clinical stage unspecified - Contact with or exposure to human immunodeficiency virus - Chronic hepatitis B Source: EML workbook import
MOQ: 1
Price on request
Zidovudine
Formulations: - Parenteral > General injections > IV: 10 mg per mL in 20 mL vial solution for IV infusion Oral > Liquid: 50 mg per 5 mL Oral > Solid > tablet: 300 mg Oral > Solid > capsule: 250 mg Indications: - Human immunodeficiency virus disease without mention of associated disease or condition, clinical stage unspecified Source: EML workbook import
MOQ: 1
Price on request
Sign Up to Our Newsletter→
Ready to amplify your rewards? Drop your email and we'll be in touch soon.